Successful response to monotherapy of immune checkpoint inhibitor in intrahepatic cholangiocarcinoma with high tumor mutational burden and PD-L1 expression

Clin Res Hepatol Gastroenterol. 2021 Jan;45(1):101525. doi: 10.1016/j.clinre.2020.08.004. Epub 2020 Sep 10.
No abstract available

Publication types

  • Letter

MeSH terms

  • B7-H1 Antigen / genetics
  • Bile Duct Neoplasms* / drug therapy
  • Bile Duct Neoplasms* / genetics
  • Bile Ducts, Intrahepatic
  • Biomarkers, Tumor
  • Cholangiocarcinoma* / drug therapy
  • Cholangiocarcinoma* / genetics
  • Humans
  • Immune Checkpoint Inhibitors

Substances

  • B7-H1 Antigen
  • Biomarkers, Tumor
  • Immune Checkpoint Inhibitors